|
Variable
|
Wild blueberry juice
|
Placebo beverage
|
P
|
|---|
|
IL-6 (pg/ml)
|
0.8 ± 0.07
|
0.9 ± 0.07
|
0.203
|
|
IL-10 (pg/ml)
|
0.28 ± 0.02
|
0.28 ± 0.02
|
0.659
|
|
CRP (ng/ml)
|
2130.4 ± 52.8
|
2141.2 ± 53.0
|
0.887
|
|
TNF-α (pg/ml)
|
2.0 ± 0.4
|
2.1 ± 0.4
|
0.399
|
|
SAA (ng/ml)
|
10.1 ± 1.1
|
10.1 ± 1.1
|
0.771
|
|
sICAM (ng/ml)
|
305.8 ± 9.6
|
311.5 ± 9.6
|
0.551
|
|
sVCAM (ng/ml)
|
969.7 ± 255.5
|
910.3 ± 256.0
|
0.665
|
|
LDL-oxidation(U/L)
|
44.5 ± 1.7
|
44.6 ± 1.7
|
0.259
|
|
Total 8-isoprostanes (pg/ml)
|
80.1 ± 8.0
|
80.8 ± 8.0
|
0.935
|
|
Nitric oxide (μM)
|
4.1 ± 0.4
|
2.9 ± 0.4
|
0.039
|
-
a
n = 19, females; all values are lsmeans ± SE. Analysis of covariance appropriate for a two period, two treatment crossover study with baseline values prior to each period; interleukin-6 (IL-6), interleukin-10 (IL-10), high sensitivity C-reactive protein (CRP), tumor necrosis factoralpha (TNF-α), serum amyloid A (SAA), soluble intercellular adhesion molecule-1 (sICAM), and soluble vascular adhesion molecule-1 (sVCAM)
